1 / 13

Vaccine Adjuvants Market To Witness Robust Expansion By 2027

Adjuvant is defined as a substance which in combination with vaccine invigorates antigen specific immune reactions to increase specificity and immunogenicity of marketed vaccines administered in any individual. Adjuvants augment the impact of a vaccine providing increased immunity towards any particular infectious disease.

jyotipolaris
Download Presentation

Vaccine Adjuvants Market To Witness Robust Expansion By 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Vaccine Adjuvants Market Market Size Worth $1,305.7 Million By 2027 | CAGR: 10.68%

  2. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 “According to Polaris Market Research report, Vaccine Adjuvants market is witnessing major innovations & transformations and is anticipated to reach $1,305.7 Million By 2027, registering a CAGR of 10.68% during the forecast period 2020 To 2027.” The global Vaccine Adjuvants market report sheds light on the key dynamics of the global market, analyzing the data on a historical basis and forecasted data till the year 2027. The market analysis covered in the report includes data in terms of value $1,305.7 Million By 2027. The market overview section of the report covers the global industry overview, microeconomic and macroeconomic outlook, and forecasted factors. The market dynamics section of this report includes major drivers, restraints, trends, and opportunities emerging in the market. Vaccine Adjuvants Market Report Scope: The global Vaccine Adjuvants market is segmented based on product/service type, end-use, and region. The motive of the research report is to define market dynamics of different countries & segments in the recent time and to forecast the values for the coming years. The report is specifically designed to incorporate quantitative and qualitative aspects of the market within each country and region involved in the study. The report caters the extensive information regarding the driving factors & hurdles that will define the future outlook for the market. Additionally, the report also incorporates prevailing and emerging opportunities for stakeholders to invest along with the in-depth detailed analysis of product/services offerings of prominent players shaping the overall development of the market. - 2 -

  3. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 By Product Type By Route of By Disease Type By Application By Region Administration •Mineral Salt- based Adjuvant •Tensoactive Adjuvants •Adjuvant Emulsions •Liposome Adjuvants •Carbohydrate Adjuvants •Bacteria- derived Adjuvants •Virus-like Particles (VLP) •Other Types •Oral •Subcutaneous •Intranasal •Intramuscular •Intradermal •Others •Infectious Diseases •Rare Diseases •Cancer •Autoimmune Disorders •Others •Research Application •Commercial Application •North America (U.S., Canada) •Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) •Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) •Latin America (Brazil, Mexico, Argentina) •Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa) COVID-19 Impact Analysis for Vaccine Adjuvants Market COVID-19 is an ongoing public health emergency that has impacted almost all industries globally, and its long- term effects are expected to influence the target industry growth over the forecast period. Our ongoing research features the COVID-19 impact analysis section as a key part of the report to uncover the major issues and potential paths forward. In this report, the insights provided in terms of changes in consumer behavior and purchasing patterns, dynamics of current market forces, re-routing of the supply chain, and the interventions of governments. The latest study incorporates analysis, estimations, insights, and forecasts, considering the COVID-19 impact on the market. Browse Detailed Research Report On Vaccine Adjuvants Market Analysis: https://www.polarismarketresearch.com/industry-analysis/vaccine-adjuvants-market Gain access to our latest research report that includes in-depth analysis of the COVID-19 pandemic impacting the the Vaccine Adjuvants market in different regions and how leading players are forming strategies to mitigate the adverse effect of the pandemic and take benefit of emerging opportunities - 3 -

  4. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 Regional Outlook Among regional markets, the region emerged as the promising regional market with its higher revenue share contribution. The growth in this regional market is primarily attributed to the ongoing technological advancements in the industry, increasing economic stability, huge government investments, and growing awareness related to the benefits of the product/service. Competitive Landscape The report offers a complete industry analysis while featuring the competitive landscape that includes company financials, product portfolios, major breakthroughs, and upcoming projects. The report includes a detailed view of the global market, along with changing scenarios, trends, regional segmentation, regional landscape, major investments, and details of historical, present, and projected revenues. According to Polaris Market Research, the key players with a noteworthy dominance in the Vaccine Adjuvants market include GlaxoSmithKline Plc, Moderna Inc., Sanofi Pasteur, Adjuvatis, Avanti Polar Lipids, Inc., SPI Pharma, MPV Technologies, Novavax, Inc., Statens Serum Institut, CSL Limited, Viscogel AB, VaxLiant LLC, Aphios Corporation, Vaxine Pty Ltd, CureVac AG, Sergeant Adjuvants, Agenus, Inc., OZ Biosciences, Adjuvants Unlimited Inc., and Adjuvants Euclid Canada Inc. Request for sample: https://www.polarismarketresearch.com/industry-analysis/vaccine-adjuvants-market/request-for-sample Table of Contents 1.Introduction 1.1.Report Description 1.1.1.Objectives of the Study 1.1.2.Market Scope 1.1.3.Assumptions 1.2.Stakeholders 2.Executive Summary 2.1.Market Highlights 3.Research Methodology 3.1.Overview 3.1.1.Data Mining 3.2.Data Sources 3.2.1.Primary Sources 3.2.2.Secondary Sources 4.Vaccine Adjuvants Market Insights 4.1.Vaccine Adjuvant – Industry snapshot 4.2.Vaccine Adjuvants Market Dynamics - 4 -

  5. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 4.2.1.Drivers and Opportunities 4.2.1.1. Surge in the infectious diseases 4.2.1.2. Government sponsored immunization programs 4.2.2.Restraints and Challenges 4.2.2.1. Side effects associated with the usage of adjuvants 4.3.Porter’s Five Forces Analysis 4.3.1.Bargaining Power of Suppliers (Moderate) 4.3.2.Threats of New Entrants: (Low) 4.3.3.Bargaining Power of Buyers (Moderate) 4.3.4.Threat of Substitute (Moderate) 4.3.5.Rivalry among existing firms (High) 4.4.PESTLE Analysis 4.5.Vaccine Adjuvants Market Industry trends 5.Vaccine Adjuvants Market Assessment by Product Type 5.1.Key Findings 5.2.Introduction 5.2.1.Global Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million) 5.3.Mineral Salt-based Adjuvant 5.3.1.Global Vaccine Adjuvants Market, by Mineral Salt-based Adjuvant, by Region, 2016- 2027 (USD Million) 5.4.Tensoactive Adjuvants 5.4.1.Global Vaccine Adjuvants Market, by Tensoactive Adjuvants, by Region, 2016- 2027 (USD Million) 5.5.Adjuvant Emulsions 5.5.1.Global Vaccine Adjuvants Market, by Adjuvant Emulsions, by Region, 2016- 2027 (USD Million) 5.6.Liposome Adjuvants 5.6.1.Global Vaccine Adjuvants Market, by Liposome Adjuvants, by Region, 2016- 2027 (USD Million) 5.7.Carbohydrate Adjuvants 5.7.1.Global Vaccine Adjuvants Market, by Carbohydrate Adjuvants, by Region, 2016- 2027 (USD Million) 5.8.Bacteria-derived Adjuvants 5.8.1.Global Vaccine Adjuvants Market, by Bacteria-derived Adjuvants, by Region, 2016- 2027 (USD Million) 5.9.Virus-like Particles (VLP) 5.9.1.Global Vaccine Adjuvants Market, by Virus-like Particles (VLP), by Region, 2016- 2027 (USD Million) 5.10. Other Types 5.10.1.Global Vaccine Adjuvants Market, by Other Types, by Region, 2016- 2027 (USD Million) 6.Global Vaccine Adjuvants Market, by Route of Administration 6.1.Key Findings 6.2.Introduction 6.2.1.Global Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million) 6.3.Oral 6.3.1.Global Vaccine Adjuvants Market, by Oral, By Region, 2016- 2027 (USD Million) 6.4.Subcutaneous - 5 -

  6. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 6.4.1.Global Vaccine Adjuvants Market, by subcutaneous, by Region, 2016- 2027 (USD Million) 6.5.Intranasal 6.5.1.Global Vaccine Adjuvants Market, by Intranasal, by Region, 2016- 2027 (USD Million) 6.6.Intramuscular 6.6.1.Global Vaccine Adjuvants Market, by Intramuscular, by Region, 2016- 2027 (USD Million) 6.7.Intradermal 6.7.1.Global Vaccine Adjuvants Market, by Intradermal, by Region, 2016- 2027 (USD Million) 6.8.Others 6.8.1.Global Vaccine Adjuvants Market, by Others, by Region, 2016- 2027 (USD Million) 7.Global Vaccine Adjuvants Market, by Disease Type 7.1.Key Findings 7.2.Introduction 7.2.1.Global Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million) 7.3.Infectious Diseases 7.3.1.Global Vaccine Adjuvants Market, by Infectious Diseases, By Region, 2016- 2027 (USD Million) 7.4.Rare Diseases 7.4.1.Global Vaccine Adjuvants Market, by Rare Diseases, by Region, 2016- 2027 (USD Million) 7.5.Cancer 7.5.1.Global Vaccine Adjuvants Market, by Cancer, by Region, 2016- 2027 (USD Million) 7.6.Autoimmune Disorders 7.6.1.Global Vaccine Adjuvants Market, by Autoimmune Disorders, by Region, 2016- 2027 (USD Million) 7.7.Others 7.7.1.Global Vaccine Adjuvants Market, by Others, by Region, 2016- 2027 (USD Million) 8.Vaccine Adjuvants Market Assessment by Application 8.1.Key Findings 8.2.Introduction 8.2.1.Global Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million) 8.3.Research Application 8.3.1.Global Vaccine Adjuvants Market, by Research Application, by Region, 2016- 2027 (USD Million) 8.4.Commercial Application 8.4.1.Global Vaccine Adjuvants Market, by Commercial Application, by Region, 2016- 2027 (USD Million) 9.Vaccine Adjuvants Market Assessment by Geography 9.1.Key findings 9.2.Introduction 9.2.1.Vaccine Adjuvants Market Assessment, By Geography, 2016- 2027 (USD Million) 9.3.Vaccine Adjuvants Market – North America 9.3.1.North America: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.3.2.North America: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) - 6 -

  7. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 9.3.3.North America: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million) 9.3.4.North America: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.3.5.Vaccine Adjuvants Market – U.S. 9.3.5.1. U.S.: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.3.5.2. U.S.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.3.5.3. U.S.: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.3.5.4. U.S.: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.3.6.Vaccine Adjuvants Market – Canada 9.3.6.1. Canada: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.3.6.2. Canada.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.3.6.3. Canada: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.3.6.4. Canada: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.4.Vaccine Adjuvants Market – Europe 9.4.1.Europe: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.4.2.Europe.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.4.3.Europe: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.4.4.Europe: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.4.5.Vaccine Adjuvants Market – UK 9.4.5.1. UK: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.4.5.2. UK.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.4.5.3. UK: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.4.5.4. UK: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.4.6.Vaccine Adjuvants Market – France 9.4.6.1. France: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.4.6.2. France.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.4.6.3. France: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.4.6.4. France: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.4.7.Vaccine Adjuvants Market – Germany 9.4.7.1. Germany: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.4.7.2. Germany.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.4.7.3. Germany: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) - 7 -

  8. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 9.4.7.4. Germany: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.4.8.Vaccine Adjuvants Market – Italy 9.4.8.1. Italy: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.4.8.2. Italy.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.4.8.3. Italy: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.4.8.4. Italy: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.4.9.Vaccine Adjuvants Market – Spain 9.4.9.1. Spain: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.4.9.2. Spain.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.4.9.3. Spain: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.4.9.4. Spain: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.4.10.Vaccine Adjuvants Market – Belgium 9.4.10.1.Belgium: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.4.10.2.Belgium.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.4.10.3.Belgium: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.4.10.4.Belgium: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.4.11.Vaccine Adjuvants Market – Austria 9.4.11.1.Austria: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.4.11.2.Austria.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.4.11.3.Austria: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.4.11.4.Austria: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.5.Vaccine Adjuvants Market – Asia-Pacific 9.5.1.Asia Pacific: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.5.2.Asia Pacific.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.5.3.Asia-pacific: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.5.4.Asia-pacific: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.5.5.Vaccine Adjuvants Market – China 9.5.5.1. China: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.5.5.2. China.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) - 8 -

  9. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 9.5.5.3. China: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.5.5.4. China: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.5.6.Vaccine Adjuvants Market – India 9.5.6.1. India: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.5.6.2. India.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.5.6.3. India: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.5.6.4. India: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.5.7.Vaccine Adjuvants Market – Malaysia 9.5.7.1. Malaysia: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.5.7.2. Malaysia.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.5.7.3. Malaysia: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.5.7.4. Malaysia: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.5.8.Vaccine Adjuvants Market – Japan 9.5.8.1. Japan: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.5.8.2. Japan.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.5.8.3. Japan: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.5.8.4. Japan: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.5.9.Vaccine Adjuvants Market – South Korea 9.5.9.1. South Korea: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.5.9.2. South Korea.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.5.9.3. South Korea: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.5.9.4. South Korea: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.5.10.Vaccine Adjuvants Market – Australia 9.5.10.1.Australia: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.5.10.2.Australia.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.5.10.3.Australia: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.5.10.4.Australia: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.6.Vaccine Adjuvants Market – Middle East & Africa 9.6.1.Middle East & Africa: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) - 9 -

  10. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 9.6.2.Middle East & Africa.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.6.3.Middle East & Africa: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.6.4.Middle East & Africa: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.6.5.Vaccine Adjuvants Market – Saudi Arabia 9.6.5.1. Saudi Arabia: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.6.5.2. Saudi Arabia.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.6.5.3. Saudi Arabia: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.6.5.4. Saudi Arabia: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.6.6.Vaccine Adjuvants Market – UAE 9.6.6.1. UAE: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.6.6.2. UAE.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.6.6.3. UAE: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.6.6.4. UAE: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.6.7.Vaccine Adjuvants Market – Israel 9.6.7.1. Israel: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.6.7.2. Israel.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.6.7.3. Israel: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.6.7.4. Israel: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.6.8.Vaccine Adjuvants Market – South Africa 9.6.8.1. South Africa: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.6.8.2. South Africa.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.6.8.3. South Africa: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.6.8.4. South Africa: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.7.Vaccine Adjuvants Market – Latin America 9.7.1.Latin America: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.7.2.Latin America.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.7.3.Latin America: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.7.4.Latin America: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.7.5.Vaccine Adjuvants Market – Mexico - 10 -

  11. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 9.7.5.1. Mexico: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.7.5.2. Mexico.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.7.5.3. Mexico: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.7.5.4. Mexico: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.7.6.Vaccine Adjuvants Market – Brazil 9.7.6.1. Brazil: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.7.6.2. Brazil.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.7.6.3. Brazil: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.7.6.4. Brazil: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.7.7.Vaccine Adjuvants Market – Argentina 9.7.7.1. Argentina: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.7.7.2. Argentina.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.7.7.3. Argentina: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.7.7.4. Argentina: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 10.Competitive Landscape 10.1. Expansion and Acquisition Analysis 10.1.1.Expansion 10.1.2.Acquisitions 10.2. Partnerships/Collaborations/Agreements/Exhibitions 11.Company Profiles 11.1. GlaxoSmithKline Plc 11.1.1.Company Overview 11.1.2.Product Benchmarking 11.1.3.Financial Performance 11.1.4.Recent Development 11.2. Moderna Inc. 11.2.1.Company Overview 11.2.2.Product Benchmarking 11.2.3.Financial Performance 11.2.4.Recent Development 11.3. Sanofi Pasteur 11.3.1.Company Overview 11.3.2.Product Benchmarking 11.3.3.Financial Performance 11.3.4.Recent Development 11.4. Adjuvatis 11.4.1.Company Overview 11.4.2.Product Benchmarking 11.4.3.Financial Performance - 11 -

  12. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 11.4.4.Recent Development 11.5. SPI Pharma 11.5.1.Company Overview 11.5.2.Product Benchmarking 11.5.3.Financial Performance 11.5.4.Recent Development 11.6. Novavax, Inc. 11.6.1.Company Overview 11.6.2.Product Benchmarking 11.6.3.Financial Performance 11.6.4.Recent Development 11.7. Sergeant Adjuvants 11.7.1.Company Overview 11.7.2.Product Benchmarking 11.7.3.Financial Performance 11.7.4.Recent Development 11.8. OZ Biosciences 11.8.1.Company Overview 11.8.2.Product Benchmarking 11.8.3.Financial Performance 11.8.4.Recent Development 11.9. Adjuvants Euclid Canada Inc. 11.9.1.Company Overview 11.9.2.Product Benchmarking 11.9.3.Financial Performance 11.9.4.Recent Development 11.10. Adjuvants Unlimited Inc. 11.10.1. Company Overview 11.10.2. Product Benchmarking 11.10.3. Financial Performance 11.10.4. Recent Development 11.11. Aphios Corporation 11.11.1. Company Overview 11.11.2. Product Benchmarking 11.11.3. Financial Performance 11.11.4. Recent Development Access Press Release on Vaccine Adjuvants Market: https://www.polarismarketresearch.com/press-releases/vaccine-adjuvants-market About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present - 12 -

  13. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 13 -

More Related